Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eurartesim vs Chloroquine for Uncomplicated Plasmodium Vivax Malaria
NCT03208907Phase 3Completed
- Sponsor
- Fundação de Medicina Tropical Dr. Heitor Vieira Dourado
- Start
- Jul 2018
- Primary completion
- Jul 2021
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dihydroartemisinin in malaria, sponsored by Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Started Jul 2018; status: completed.
02
Drugs
dihydroartemisinin
03
Conditions
malaria
Beyond the preview
Go deeper on NCT03208907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03208907.